Sources | Names Used |
---|---|
CTRPv2 | 1S,3R-RSL-3 |
PharmacoGx | 1S,3R-RSL-3 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AKR1B15 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-07 |
mRNA | CCDC177 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
mRNA | C14orf132 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |
mRNA | TKT | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-07 |
mRNA | C20orf24 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-07 |
mRNA | CYP4F3 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-07 |
mRNA | FBXW10 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-07 |
mRNA | ABCC2 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-07 |
mRNA | RP11-385D13.1 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-07 |
mRNA | TRIM16 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-07 |